OCR
REFERENCES = 101 Meshack, A., Peters, R. ]., Jr., Lin, M.-T., Hill, M., Abughosh, S., & Essien, E. J. (2013). The beliefs of teenage male cannabinoid users: a qualitative study. American Journal of Health Studies, 28(3), 109-113. Miller, G. D., & Baldwin, J. D. C. (1987). Implications of the wounded-healer paradigm for the use of the self in therapy. Journal of Psychotherapy & the Family, 3(1), 139-151. Milligan, D., McCarthy-Jones, S., Winthrop, A., & Dudley, R. (2012). Time changes everything? A qualitative investigation of the experience of auditory verbal hallucinations over time. Psychosis, 5(2), 107-118. doi: 10.1080/17522439.2012.667438 Milligan, D., McCarthy-Jones, S., Winthrop, A., & Dudley, R. (2013). Time changes everything? A qualitative investigation of the experience of auditory verbal hallucinations over time. Psychosis, 5(2), 107-118. doi: 10.1080/17522439.2012.667438 Moré, L., & Racz, J. (2013). Online drug user-led harm reduction in Hungary: a review of “Daath”. Harm Reduction Journal, 10(1), 18. Miiller, Kornhuber, J., & Sperling, W. (2015). The behavioral profile of spice and synthetic cannabinoids in humans. Brain Research Bulletin. doi: 10.1016/j.brainresbull.2015.10.013 Müller, Sperling, W., Köhrmann, M., Huttner, B. H., Kornhuber, ]J., & Maler, J. M. (2010). The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophrenia Research, 118, 309-310. Nacca, N., Vatti, D., Sullivan, R., Sud, P, Su, M., & Marraffa, J. (2013). The synthetic cannabinoid withdrawal syndrome. Journal of Addiction Medicine, 7(4), 296-298. doi: 10.1097/ADM.0b013e31828e1881 Nagy, Z. (2015). “..életiink minden megnyilvanuldsdban.” A felépiilés életrendje és értékrendje 12 lépéses programokban józanodó szerfüggők körében. Eötvös Lóránd University, Budapest. Nakajima, J. i., Takahashi, M., Seto, T., Kanai, C., Suzuki, J., Yoshida, M.,... Hamano, T. (2013). Analysis of azepane isomers of AM-2233 and AM-1220, and detection of an inhibitor of fatty acid amide hydrolase [3’-(aminocarbonyl)(1, 1'-biphenyl)3-yl]-cyclohexylcarbamate (URB597) obtained as designer drugs in the Tokyo area. Forensic Toxicology, 31(1), 76-85. National Institute of Mental Health. Questions and answears about psychosis. Retrieved 26-01-2019, from https://www.nimh.nih.gov/health/topics/schizophrenia/ raise/raise-questions-and-answers.shtml#1 Newton, E., Larkin, M., Melhuish, R., & Wykes, T. (2007). More than just a place to talk: Young people’s experiences of group psychological therapy as an early intervention for auditory hallucinations. Psychology and Psychotherapy: Theory, Research and Practice, 80(1), 127-149. doi: 10.1348/147608306X110148 Nuevo, R., Chatterji, S., Verdes, E., Naidoo, N., Arango, C., & Ayuso Mateos, J. L. (2012). The continuum of psychotic symptoms in the general population: a cross-national study. Schizophrenia Bulletin, 38(475-485). doi: doi: 10.1093/schbul/sbq099